UAB first in U.S. to test new emphysema procedure

A patient at the University of Alabama at Birmingham (UAB) became the first person in America to undergo an investigational therapy for emphysema that uses a foam sealant sprayed into the lungs.
On Oct. 29, 2012, Perry Waldrop, 55, of Cullman, Ala., was treated in a late-stage clinical trial of the AeriSeal System. The therapy, approved for use in parts of Europe and Israel, is undergoing investigation in the United States as a potential method of reducing lung volume in patients with severe emphysema. Read story here: bit.ly/VwnUlg

[@scottprendergast5262]

The doctor sounds.like.kevin bacons.doing a voice over for him

[@mrmcclear]

How is Perry doing? Would love an update.

[@StevenGregory-rn6zh]

How long does this procedure last

[@StevenGregory-rn6zh]

Is still a live